ViroXis, a bio-pharmaceutical company, develops botanical pharmaceuticals derived from sandalwood oil.
ViroXis is a bio-pharmaceutical company focused on developing and commercializing innovative, properietary, botanical pharmaceuticals derived from Sandalwood Oil. The hardwood oils of the East Indian and West Australian sandalwood trees, S.album and S. spicatum, have a long and extensive history of traditional use for a variety of conditions, including the successful treatment of various skin disorders, including skin viral and difficult-to-treat microbial infections.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 31, 2012 | Series Unknown | $1.01M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Greer Capital Advisors | — | Series Unknown |